12 Startups Fighting Cancer With Artificial Intelligence

#artificialintelligence

As the global population ages, the number of cancer cases is going up. New cancer diagnoses are expected to rise by 70% in the next 2 decades, from 14 million to around 22 million, according to an estimate by the World Health Organization. Corporate giants like Google and IBM are already focusing on making breakthroughs in oncology, using advanced AI algorithms for early detection and personalized treatment of cancer. Google DeepMind announced a research partnership with the University College London Hospitals' radiotherapy department. DeepMind will test the use of machine learning to reduce the time it takes to plan radiotherapy treatment for hard-to-treat cancers of the head and neck.


12 Startups Fighting Cancer With Artificial Intelligence

#artificialintelligence

As the global population ages, the number of cancer cases is going up. New cancer diagnoses are expected to rise by 70% in the next 2 decades, from 14 million to around 22 million, according to an estimate by the World Health Organization. Corporate giants like Google and IBM are already focusing on making breakthroughs in oncology, using advanced AI algorithms for early detection and personalized treatment of cancer. We used the CB Insights database to find equity-funded startups that are using artificial intelligence to fight cancer. California-based CureMetrix has developed an algorithm for image analysis, which is currently being tested to identify lung cancer in x-rays and for breast cancer detection in mammograms.


From Virtual Nurses To Drug Discovery: 90 Artificial Intelligence Startups In Healthcare

#artificialintelligence

Increasingly crowded imaging & diagnostics: 17 out of the 22 companies under imagining & diagnostics raised their first equity funding round since January 2015 (this includes 1st Seed or Series A rounds, as well as a first round raised by stealth startup Imagen Technologies). In 2014, Butterfly Networks raised a $100M Series C, backed by Aeris Capital and Stanford University. This was the third-largest equity round to AI in healthcare companies, after China-based iCarbonX's $154M mega-round and two $100M raises by oncology-focused Flatiron Health. VCs invest in drug discovery: Startups are using machine learning algorithms to reduce drug discovery times, and VCs have backed 6 out of the 9 startups on the map. Andreessen Horowitz recently seed-funded twoXAR, developer of the DUMA drug discovery platform; Khosla Ventures and Data Collective backed Atomwise, which published its first findings of Ebola treatment drugs last year, and has also partnered with MERCK; Lightspeed Venture Partners invested in Numedii in 2013; Foundation Capital participated in 3 equity funding rounds to Numerate.


Startups Disrupting Healthcare with AI and Machine Learning

#artificialintelligence

Increasingly crowded imaging & diagnostics: 17 out of the 22 companies under imagining & diagnostics raised their first equity funding round since January 2015 (this includes 1st Seed or Series A rounds, as well as a first round raised by stealth startup Imagen Technologies). In 2014, Butterfly Networks raised a $100M Series C, backed by Aeris Capital and Stanford University. This was the third-largest equity round to AI in healthcare companies, after China-based iCarbonX's $154M mega-round and two $100M raises by oncology-focused Flatiron Health. VCs invest in drug discovery: Startups are using machine learning algorithms to reduce drug discovery times, and VCs have backed 6 out of the 8 startups on the map. Andreessen Horowitz recently seed-funded twoXAR, developer of the DUMA drug discovery platform; Khosla Ventures and Data Collective backed Atomwise, which published its first findings of Ebola treatment drugs last year, and has also partnered with MERCK; Lightspeed Venture Partners invested in Numedii in 2013; Foundation Capital participated in 3 equity funding rounds to Numerate.


From Virtual Nurses To Drug Discovery: 32 Artificial Intelligence Startups In Healthcare

#artificialintelligence

Earlier this year, consulting firm Frost & Sullivan predicted that artificial intelligence in healthcare will see a "dramatic market expansion" in the next couple of years, with the potential to reduce the cost of medical treatments by half across the board. "By 2025, AI systems could be involved in everything from population health management, to digital avatars capable of answering specific patient queries," said Harpreet Singh Buttar, an analyst at Frost & Sullivan. With this in mind, we identified 32 companies that are already applying machine learning techniques and predictive analytics to reduce drug discovery times, provide virtual assistance to patients, and diagnose ailments by processing medical images, among other things. The 32 startups on the list have raised more than 530M in aggregate funding. This year, New York-based AiCure raised 12.3M in Series A funding and National Science Foundation-grantee Cloud Pharmaceuticals raised a 350K round from undisclosed investors.